U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)

iData Research, Inc.
September 1, 2011
322 Pages - SKU: IDR6505087
Countries covered: United States

By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include:

  • Immunochemistry,
    • Immunochemistry Analyzer
    • Immunology Diagnostic
    • Chemistry Diagnostics
    • Automated Urinalysis Instrument
  • Molecular Diagnostics
    • Molecular Diagnostics Reagent
    • Molecular Diagnostics Instrument
  • Hemostasis
    • Hemostasis Analyzer
    • Hemostasis Reagent
  • Hematology
    • Hematology Analyzer Market
    • Hematology Reagent
  • Blood Donor Screening
    • Blood Screening Analyzer
    • Blood Screening Assay Kit
  • Point-of-Care Testing
    • Blood Gas Testing
    • Urinalysis Testing
    • Blood Glucose Testing
In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food and Drug Administration (FDA) approved assays. That year, many technologies were well established and equipment markets were saturated. However, innovation, demand for testing and development of new assays will drive market growth.

Within the in vitro diagnostics market, companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.




More United States Coagulation reports

Coagulation Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations - 2014 by Venture Planning Group
2014 Coagulation Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations Summary This comprehensive report contains 455 pages, 60 tables, and is ...
New Frontiers in the US Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape by Venture Planning Group
Summary; New Frontiers in the U.S. Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape; is Venture Planning Group's new report designed to help ...
The United States Market for In Vitro Diagnostic Tests by Kalorama Information
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, ...
The US Coagulation Testing Market 2014: Reagent and Instrumentation Sales Forecasts by Market Segment, Supplier Shares by Venture Planning Group
The US Coagulation Testing Market 2014: Reagent and Instrumentation Sales Forecasts by Market Segment, Supplier Shares This report provides an overview of the US ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 7,495  
    Global Site License Fulfilled by Publisher  USD 8,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!